News & Updates

Managing liver derangement in COVID-19: Recommendations for clinicians

05 Aug 2020 by

In view of the prevalence and prognostic significance of liver derangement in patients with coronavirus disease 2019 (COVID-19), the Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic has issued practical recommendations on 12 clinical scenarios commonly encountered by physicians.

Managing liver derangement in COVID-19: Recommendations for clinicians

05 Aug 2020

Secondary hepatic dysfunction common among infants in ICU

03 Aug 2020

Secondary hepatic dysfunction is prevalent in paediatric intensive care units (PICUs), a recent study has found. Risk factors include sepsis, hypoxia, and cardiovascular incidents.

Secondary hepatic dysfunction common among infants in ICU

03 Aug 2020

Low retransplantation rate tied to increased mortality in recurring autoimmune hepatitis

30 Jul 2020

The low rate of retransplantation in patients with recurring autoimmune hepatitis (AIH) is partly to blame for the greater post-transplant mortality in this population compared with other autoimmune liver disease, suggests a recent study.

Low retransplantation rate tied to increased mortality in recurring autoimmune hepatitis

30 Jul 2020

Givosiran holds promise for rare genetic disorder

30 Jul 2020 by

Patients with acute intermittent porphyria (AIP) – the most common subtype of acute hepatic porphyria (AHP) – had significantly reduced attack rates, as well as improvements in other parameters, with givosiran, the phase III ENVISION trial has shown.

Givosiran holds promise for rare genetic disorder

30 Jul 2020

HCV treatment cuts liver-related mortality

27 Jul 2020

The survival benefits associated with treating hepatitis C virus (HCV) infections are driven primarily by a reduction in liver-related mortality, a recent study has found.

HCV treatment cuts liver-related mortality

27 Jul 2020

Large gaps in Malaysians’ self-awareness of hepatitis B infection

24 Jul 2020 by

Seven-in-eight Malaysians living with hepatitis B infection may not know it, with concerning ramifications for public health, according to a recent study.

Large gaps in Malaysians’ self-awareness of hepatitis B infection

24 Jul 2020

ELF test delivers limited specificity for predicting advanced fibrosis

23 Jul 2020

The enhanced liver fibrosis (ELF) test is sensitive but has limited specificity for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease, a recent meta-analysis has found.

ELF test delivers limited specificity for predicting advanced fibrosis

23 Jul 2020

HBV, HCV screening low among Japanese workers

22 Jul 2020

Screening for hepatitis B and C is low among workers in Japan, a recent study has found. Public funding and government efforts to screen workers should be considered.

HBV, HCV screening low among Japanese workers

22 Jul 2020

Ivosidenib a ray of hope for rare biliary tract cancer?

22 Jul 2020 by

Ivosidenib, a potent targeted inhibitor of mutated IDH1*, provided benefit for patients with IDH1-mutant, chemotherapy(CT)-refractory cholangiocarcinoma (CC), the ClarIDHy study has shown.

Ivosidenib a ray of hope for rare biliary tract cancer?

22 Jul 2020

Liver injury associated with adverse outcomes in COVID-19

22 Jul 2020 by

Abnormal liver biochemistries and acute liver injury, associated with the use of lopinavir-ritonavir and/or corticosteroids, significantly increase the risk of adverse clinical outcomes in patients with coronavirus disease 2019 (COVID-19), a territory-wide retrospective cohort study in Hong Kong has shown.

Liver injury associated with adverse outcomes in COVID-19

22 Jul 2020

News & Updates

Filter by Specialty:

Specialty:

Managing liver derangement in COVID-19: Recommendations for clinicians

Managing liver derangement in COVID-19: Recommendations for clinicians

Secondary hepatic dysfunction common among infants in ICU

Secondary hepatic dysfunction common among infants in ICU

Low retransplantation rate tied to increased mortality in recurring autoimmune hepatitis

Low retransplantation rate tied to increased mortality in recurring autoimmune hepatitis

Givosiran holds promise for rare genetic disorder

Givosiran holds promise for rare genetic disorder

HCV treatment cuts liver-related mortality

HCV treatment cuts liver-related mortality

Large gaps in Malaysians’ self-awareness of hepatitis B infection

Large gaps in Malaysians’ self-awareness of hepatitis B infection

ELF test delivers limited specificity for predicting advanced fibrosis

ELF test delivers limited specificity for predicting advanced fibrosis

HBV, HCV screening low among Japanese workers

HBV, HCV screening low among Japanese workers

Ivosidenib a ray of hope for rare biliary tract cancer?

Ivosidenib a ray of hope for rare biliary tract cancer?

Liver injury associated with adverse outcomes in COVID-19

Liver injury associated with adverse outcomes in COVID-19